Sign In
Buy DGX
$193.67
+0.510 (+0.264%)
At Close: Jun 03, 2026
Quest Diagnostics' (DGX) Haystack Oncology Forges New MRD Deal
08:51am, Wednesday, 24'th Jul 2024
Quest Diagnostics' (DGX) subsidiary, Haystack Oncology, partners on the use of its MRD technology.
Quest Diagnostics' Q2 Earnings Performance Suggests Stable Stock, Modest Growth Ahead, Analyst Says
04:12pm, Tuesday, 23'rd Jul 2024
On Tuesday, Quest Diagnostics Inc DGX posted second-quarter adjusted EPS of $2.35, beating the consensus of $2.34.
Quest Diagnostics Incorporated (DGX) Q2 2024 Earnings Call Transcript
12:12pm, Tuesday, 23'rd Jul 2024
Quest Diagnostics Incorporated (NYSE:DGX ) Q2 2024 Earnings Conference Call July 23, 2024 8:30 AM ET Company Participants Jim Davis - Chairman, Chief Executive Officer, President Sam Samad - Chief Fin
Quest Diagnostics (DGX) Tops Q2 Earnings, Raises 2024 Outlook
11:06am, Tuesday, 23'rd Jul 2024
Quest Diagnostics (DGX) delivers impressive base business growth in the second quarter of 2024.
Quest Diagnostics (DGX) Q2 Earnings and Revenues Top Estimates
08:55am, Tuesday, 23'rd Jul 2024
Quest Diagnostics (DGX) came out with quarterly earnings of $2.35 per share, beating the Zacks Consensus Estimate of $2.31 per share. This compares to earnings of $2.30 per share a year ago.
Quest Diagnostics raises 2024 profit, revenue forecasts on health tests demand
08:19am, Tuesday, 23'rd Jul 2024
Quest Diagnostics raised its 2024 profit and revenue forecasts on Tuesday, banking on robust demand for its health tests.
Quest Diagnostics Reports Second Quarter 2024 Financial Results; Raises Guidance for Full Year 2024
06:45am, Tuesday, 23'rd Jul 2024
Second quarter revenues of $2.40 billion, up 2.5% from 2023 Second quarter reported diluted earnings per share ("EPS") of $2.03, down 1.0% from 2023; and adjusted diluted EPS of $2.35, up 2.2% from 20
BALTIMORE, Md. and BASKING RIDGE, N.J., July 18, 2024 (GLOBE NEWSWIRE) -- Haystack Oncology, a Quest Diagnostics (NYSE: DGX) company, and Lisata Therapeutics, Inc. (Nasdaq: LSTA), a clinical-stage pha
Here's Why Quest Diagnostics (DGX) is a Strong Value Stock
10:51am, Wednesday, 17'th Jul 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Quest Diagnostics Incorporated (DGX) Soars to 52-Week High, Time to Cash Out?
10:15am, Tuesday, 16'th Jul 2024
Quest Diagnostics (DGX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Quest Diagnostics (DGX) Set to Acquire OhioHealth's Lab Services
09:36am, Monday, 15'th Jul 2024
Quest Diagnostics' (DGX) new agreement is likely to help expand access to cost-effective and advanced laboratory services in Ohio.
What Awaits Quest Diagnostics (DGX) in Q2 Earnings Release?
10:41am, Friday, 12'th Jul 2024
Quest Diagnostics (DGX) is likely to have maintained its robust base business performance in the second quarter of 2024. However, nosediving COVID-19 testing revenues may limit growth.
Quest Diagnostics to Acquire Outreach Laboratory Services of OhioHealth
08:58am, Wednesday, 10'th Jul 2024
Goal to broaden access to cost-effective and innovative laboratory services in Ohio SECAUCUS, N.J. and COLUMBUS, Ohio , July 10, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider
Quest Diagnostics (DGX) to Expand in Canada With LifeLabs Buyout
12:15pm, Thursday, 04'th Jul 2024
By integrating LifeLabs into its operations, Quest Diagnostics (DGX) aims to enhance the accessibility and quality of diagnostic services for Canadians.
Quest Diagnostics to acquire LifeLabs for $985 million
09:01am, Wednesday, 03'rd Jul 2024
Quest Diagnostics said on Wednesday it would acquire LifeLabs, a provider of community laboratory tests, from OMERS for about C$1.35 billion, or about $985 million.
